NeoGenomics Announces CEO Departure and Initiates CEO Search
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
NeoGenomics (NEO) Stock Plunges as CEO Abruptly Resigns and Co. Warns for Q1, Prompting Two Street Downgrades
March 29, 2022 9:12 AM EDTNeoGenomics (NASDAQ: NEO) shares have collapsed 29% in pre-open trading Tuesday after announcing that CEO Mark Mallon will be stepping down from the top role and the board. In addition, the company said it now sees first-quarter revenue below the low end of its prior guidance of $118 - $120 million and EBITDA for the quarter below the low end... More
Neogenomics (NEO) PT Lowered to $24 at Cowen
March 29, 2022 7:12 AM EDTCowen analyst Dan Brennan lowered the price target on Neogenomics (NASDAQ: NEO) to $24.00 (from $42.00) while maintaining an Outperform rating after the CEO resigned and Q1 was lowered.
The analyst commented, "Following news of a sudden CEO departure, limited visibility on new... More
Neogenomics (NEO) PT Lowered to $19 at Needham & Company
March 29, 2022 6:34 AM EDTNeedham & Company analyst Mike Matson lowered the price target on Neogenomics (NASDAQ: NEO) to $19.00 (from $29.00) while maintaining a Buy rating.
The analyst commented, "NEO announced the departure of CEO Mark Mallon. We believe that this was not a voluntary decision and may... More
